ADP-26624-59710

Timeline

1. 2021-03-10
   Registered in v-safe
2. 2021-03-10
   Dose 1 — Janssen/Johnson & Johnson
3. 2021-03-10
   Health check-in — day 0, dose 1

   Feeling: Good · Site: Pain, Swelling · None · Be unable to work

   Adult check-in
4. 2021-03-11
   Health check-in — days 1–6 daily, dose 1

   Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

   Adult check-in
5. 2021-03-12
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · Site: Redness, Swelling, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness

   Adult check-in
6. 2021-03-13
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · Site: Pain, Redness, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

   Adult check-in
7. 2021-03-14
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · Site: Swelling, Itching · None

   Adult check-in
8. 2021-09-08
   Survey response — 6 months, dose 1

   MedDRA: Brain fog, Fatigue — Feeling: Fair

   Free text: Foggyness, fatigue.

   MedDRA releases: 2024-11 · check-in free text available
9. 2022-03-10
   Survey response — 12 months, dose 1

   MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

   Free text: I had Covid.

   MedDRA releases: 2024-11 · check-in free text available
10. 2022-03-10
    Report sent to call center — 12 months, dose 1

    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

    Telehealth, virtual health, or email health consultation · 1 call case(s)
11. 2022-03-11
    Call successful

    Does not wish to fill out VAERS report